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Aim: To determine the urease inhibitory potential of extracts and isolated compounds from Zizyphus oxyphylla Edgew.
Materials and methods: Methanolic extracts and subsequent fractions of Z. oxyphylla stem and 3 isolated compounds from the roots of
Z. oxyphylla were obtained through column chromatography and subjected to in vitro urease inhibition.
Results: Three fractions (n-hexane, ethyl acetate, and butanol fractions) showed good to excellent activity, while the chloroform fraction
showed nonsignificant activity. Amongst the isolated compounds, oxyphylline D (1) was the most active of the 3 isolated cyclopeptide
alkaloids, followed by nummularin R (3) and nummularin C (2).
Conclusion: Z. oxyphylla has the potential to be used in the treatment of various complications produced by urease enzymes, such as
gastric ulcers.
Key words: Zizyphus oxyphylla, cyclopeptide alkaloids, urease

1. Introduction
Urease is a nickel-containing enzyme and it catalyzes the
production of ammonia and carbon dioxide from urea.
It is important in the pathogenesis of various diseases
in humans as it can act as a virulence factor for various
bacteria (1). It plays an important role in the production
of gastric ulcers as it locally neutralizes the gastric acid by
the production of ammonia, thus providing an appropriate
microenvironment for the existence of Helicobacter pylori,
which is a major cause of illness and death worldwide (2).
In addition, it can cause peptic ulcers by the production of
a high concentration of ammonia, which disturbs mucosal
permeability for hydrogen ions. Previous reports have
suggested that urease-producing bacteria play a prominent
role in the formation of infection-induced urinary stones
(3). Therefore, scientists are constantly searching for
compounds that can inhibit urease enzyme, thus avoiding
the above-mentioned diseases.
Plants are old friends of humans, who rely on
them directly or indirectly for food, shelter, aesthetic
* Correspondence: sercisli@gmail.com

purposes, and for the treatment of disease. Plants can
be considered biological factories for the production of
various medicinal compounds. Hence plants attract the
common man as well as the scientific community for the
investigation, authentication, and rationalization of their
food and therapeutic effects (4). Pakistan is well known for
its luxuriant flora, a major portion of which has not been
studied (5), and so there is a need to explore the hidden
medicinal potential of these plants.
Zizyphus, an important member of the family
Rhamnaceae, possesses analgesic, antiinflammatory (6–9),
antispasmodic (10), hepatoprotective (11), antidiabetic
(12), and antioxidant activities (13). It has also been
found that some species have antiulcerogenic activity
(14). Zizyphus oxyphylla Edgew. has already been screened
for its antibacterial, antifungal, phytotoxic, cytotoxic,
insecticidal, and antinociceptive activities (15–17). Some
cyclopeptide alkaloids isolated have exhibited antibacterial
activities (18), while oil obtained from its stem and leaves
also showed antimicrobial activity (19). However, no work

497

KALEEM et al. / Turk J Med Sci
exists on the urease inhibition potential of this plant;
therefore, the current study was designed to test for this.
2. Materials and methods
2.1. Plant collection, extraction, and isolation of
compounds
Plant material (stem and roots) was collected from the
Swat district, Khyber Pukhtun Khwa Province, Pakistan,
and identified by a recognized taxonomist, Dr Hasan Sher,
Department of Botany, Jehanzeb Postgraduate College,
Saidu Sharif Swat.
Air dried powdered roots of Z. oxyphylla (8 kg)
were macerated in methanol (3 × 7 days × 20 L). On
removal of the solvent under vacuum at between 35 and
40 °C, 372 g of crude extract was obtained, which was
partitioned between water and dichloromethane. The
dichloromethane extract (2.5 g) was subjected to column
chromatography (CC) using silica gel (300 mm × 20 mm)
and hexanes/acetone/diethylamine (75:25:0.1, 10 L) to
afford 8 fractions (A–H). Compounds 1 (10.2 mg) and 2
(8.7 mg) were obtained from fractions D (41.3 mg) and E
(53.4 mg) by preparative thin-layer chromatography (TLC)
(hexanes/acetone/diethyl amine, 15:10:1). Air dried stem
powder (8 kg) was extracted in a similar manner to give
375 g of crude extract, which was partitioned into various
fractions, depending upon the polarity of the solvents, and
so n-hexane, chloroform, ethyl acetate, n-butanol, and
aqueous fractions were obtained as reported previously
(15–18). The chloroform extract (11.0 g) was subjected
to CC over silica gel (325 mm × 65 mm) with hexanes/
acetone/diethylamine (75:25:0.1, 10 L) to afford 8 fractions
(A–H). Fraction C (202 mg) was subjected to preparative
TLC (hexanes/acetone/diethylamine, 15:10:1) to obtain
compound 3 (6.1 mg).
2.2. Urease inhibition bioassay
Enzyme (jack bean, 25 mL) and 55 mL of a buffer containing
100 mM of urea were incubated with 5 mL of test samples
(0.5 mM concentration) in 96 well plates at 30 °C for 15
min. The indophenols method was used to determine
the urease activity by measuring ammonia production.
Phenol reagent and alkali reagent were prepared and 45
mL of phenol reagent and 70 mL of alkali reagent were
added to every well. The increasing absorbance at 630
nm was measured after 50 min, using a microplate reader
(Molecular Devices, Sunnyvale, CA, USA)
The change in absorbance per minute was noted and the
results processed using Soft-Max Pro software (Molecular
Devices). All the tests were performed in triplicate. During
all this assay pH was maintained at 8.2 by K2HPO4.3H2O
(0.01 M), EDTA (1.0 mM), and LiCl2 (0.01 M). Thiourea
was used as a standard drug. The following formula was
used to calculate the percent inhibition (20):
Percent inhibition = 100 − (ODtest well /ODcontrol) × 100
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3. Results
The 3 compounds isolated from Z. oxyphylla were identified
first. Compound 1 was found to be oxyphylline D and
compounds 2 and 3 were identified to be nummularin
C and R (Figure). In this work we studied the urease
inhibitory potential of these 3 compounds as well as crude
extract of the plant and various fractions thereof.
The urease inhibitory activity of crude extract from the
stem of Z. oxyphylla and its various fractions are presented
in Table 1. It is obvious from this table that the maximum
urease inhibitory activity was shown by the ethyl acetate
fraction (% inhibition = 86.7 ± 0.03, IC50 ± SEM = 43.4
± 2.01). It was followed by the butanol fraction, which
produced a % inhibition of 81.2 ± 0.01 with 49.8 ± 1.06
IC50 ± SEM value. The crude extract also exhibited good
urease inhibitory activity, while the aqueous fraction gave
a reading of 63.1 ± 0.02 and 164.7 ± 2.31 for IC50 ± SEM.
The chloroform fraction of the stem exhibited a low urease
inhibitory activity, giving a reading of 18.9% ± 0.02, while
the n-hexane fraction provided a nonsignificant activity of
3.8%.
Table 1. Urease inhibitory activity of stem.
Samples

% Inhibition

IC50 ± SEM

Crude extract

75.8 ± 0.03

105.2 ± 1.61

n-hexane fraction

3.8 ± 0.01

-

Chloroform fraction

18.9 ± 0.02

-

Ethyl acetate fraction

86.7 ± 0.03

43.4 ± 2.01

Butanol fraction

81.2 ± 0.01

49.8 ± 1.06

Aqueous fraction

63.1 ± 0.02

164.7 ± 2.31

standard

98.1 ± 0.02

21 ± 0.011

The urease inhibitory potentials of various
cyclopeptide alkaloids from Z. oxyphylla are given in Table
2. Compound 1 was the most active of the 3. It exhibited
good activity at 58.2 ± 0.02% and IC50 ± SEM 420.1 ± 1.22,
while compound 2 exhibited the lowest. It exhibited a 29%
urease inhibitory activity. Compound 3 showed a low to
moderate activity of 35.7 ± 0.02.
4. Discussion
There has been increasing interest in studying the biological
properties of plant extracts and isolated compounds
globally (18,21–24). Researchers are blending traditional
knowledge with experimental methodology for testing the
efficacy and safety of these herbal remedies (25,26). The
current study is a part of these efforts.
The order of urease inhibitory activity observed for
crude extract and fractions obtained from the stem of Z.
oxyphylla was ethyl acetate > butanol > crude > aqueous
> chloroform > n-hexane. It is obvious from Table 1 that
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Table 2. Urease inhibitory activity of isolated compounds.
Compound

Concentration(mM)

1
2

% Inhibition

IC50 ± SEM (µM)

58.2 ± 0.02

420.1 ± 1.22

29.3 ± 0.01

-

3

35.7 ± 0.02

-

STD

98.1 ± 0.2

21 ± 0.011

0.5

Oxyphylline D (1)

Nummularin C (2)

Nummularin R (3)

Figure. Structure of compounds isolated from Z. oxyphylla.

ethyl acetate and n-hexane fractions are the most active
and the least active respectively. The activity present
in crude extract and fractions is due to the presence of
various bioactive constituents (27,28). The distribution
of these bioactive constituents in various fractions varies
according to the solvents used. The results indicated that
the maximum chances of bioactive constituents presence
was in the ethyl acetate fraction, and so this fraction was
subjected to CC for isolation of compounds. Compound
3 was isolated and identified as numularin R, while
compounds 1 and 2 were identified as oxyphylline D and
numularin C respectively. The order of urease inhibitory
activity observed for these compounds was oxyphylline

D > numularin R > numularin C. It is generally accepted
that activities exhibited by isolated compounds depend
on the structure of the compound. The current results
authenticate the traditional usage of this plant as antiulcer
remedy. Other species of this genus Zizyphus have been
reported to have antiulcer activity (11). Antibiotics are
an effective remedy against ulcers produced by H. pylori
infection but now people are turning towards natural
products because of the increasing problem of antibiotic
resistance, side effects, and the significant cost of synthetic
drugs. This plant has the potential to be used in the
treatment of various complications produced by urease
enzymes, such as gastric ulcers.
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